TITLE

2009 - Fondaparinux led to less bleeding than enoxaparin in patients with non-ST-elevation acute coronary syndromes

AUTHOR(S)
Borzak, Steven
PUB. DATE
July 2009
SOURCE
ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on a study on how fondaparinux and enoxaparin compare for bleeding in patients with non-ST-elevation acute coronary syndromes (ACSs). The result of the study concluded that in patients with non-ST-elevation acute coronary syndromes, fondaparinux reduced fatal, nonfatal major, and minor bleeding at 9 days and nonfatal major and minor bleeding at 180 days, compared with enoxaparin.
ACCESSION #
43797541

 

Related Articles

  • Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes.  // New England Journal of Medicine;4/6/2006, Vol. 354 Issue 14, p1464 

    Background: The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We therefore assessed whether fondaparinux would preserve the anti-ischemic benefits of...

  • EXERTION AND ACUTE CORONARY ARTERY INJURY. Black, Asher; Black, Martin M.; Gensini, Goffredo // Angiology;Dec1975, Vol. 26 Issue 11, p759 

    Twelve cases of myocardial infarction as related to strenuous exertion are presented with the pathological findings in several of these cases. Three cases with coronary arteriography are also presented. The pathology of coronary arteriosderotic plaques and the vulnerability to acute injury is...

  • First patients treated with vProtect.  // Cardiovascular Devices & Drugs;Jul2008, Vol. 14 Issue 7, p23 

    The article reports on the first administration of the vProtect Luminal Shield self-expanding intracoronary prosthesis from Prescient Medical in May 2008. Three patients with established cardiac ischemia were the first recipients of the prosthesis which was designed to limit arterial injury...

  • Utility of multislice computed tomography as a strategic tool for complex percutaneous coronary intervention. Masato Otsuka; Shigetada Sugahara; Ken Umeda; Mitsuchika Nakamura; Ayako Nakamura; Yukihiro Bonkohara; Yukio Tsurumi // International Journal of Cardiovascular Imaging;Feb2008, Vol. 24 Issue 2, p201 

    Abstract Objectives  Multislice computed tomography (MSCT) has been currently utilized as a non-invasive diagnostic modality to detect coronary artery disease. We sought to investigate whether preprocedural lesion assessment by MSCT could offer strategic guidance in the setting...

  • ACUITY at 1 year.  // Heart;Apr2008, Vol. 94 Issue 4, p535 

    The article discusses the result of Acute Catherization and Urgent Intervention Triage Strategy (ACUITY) one-year trial. It states that the ACUITY trial demonstrated that in patients with moderate and high-risk acute coronary syndromes undergoing early invasive treatment, bivalirudin monotherapy...

  • ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB.  // Evidence Based Medicine;Jul2003, p99 

    A bibliography on medical subjects, which includes the articles about acute coronary syndromes, invasive candidiasis treatment and acute ischaemic stroke.

  • Anticoagulation therapy. Kakar, Puneet; Lip, Gregory Y. H. // GP: General Practitioner;12/8/2006, p22 

    The article presents information on the use of anticoagulation therapy in the treatment of acute coronary syndromes and acute cerebral ischaemic syndromes. Anticoagulants like warfarin and heparin are used in the therapy to prevent blood coagulation. Therapeutic anticoagulation avoids...

  • Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non--ST-Segment Elevation Acute Coronary Syndromes. Fox, Keith A. A.; Bassand, Jean-Pierre; Mehta, Shamir R.; Wallentin, Lars; Theroux, Pierre; Piegas, Leopoldo Soares; Valentin, Vicent; Moccetti, Tiziano; Chrolavicius, Susan; Afzal, Rizwan; Yusuf, Salim // Annals of Internal Medicine;9/4/2007, Vol. 147 Issue 5, p304 

    Background: A recent randomized, controlled trial, the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS 5) trial, reported that major bleeding was 2-fold less frequent with fondaparinux than with enoxaparin in acute coronary syndromes (ACS). Renal dysfunction increases...

  • Developmental origin of age-related coronary artery disease. Ke Wei; Díaz-Trelles, Ramon; Qiaozhen Liu; Diez-Cuñado, Marta; Scimia, Maria-Cecilia; Wenqing Cai; Sawada, Junko; Komatsu, Masanobu; Boyle, Joseph J.; Bin Zhou; Ruiz-Lozano, Pilar; Mercola, Mark // Cardiovascular Research;7/15/2015, Vol. 107 Issue 2, p287 

    Aim: Age and injury cause structural and functional changes in coronary artery smooth muscle cells (caSMCs) that influence the pathogenesis of coronary artery disease. Although paracrine signalling is widely believed to drive phenotypic changes in caSMCs, here we show that developmental origin...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics